Establishment Labs Revenue and Competitors
Estimated Revenue & Valuation
- Establishment Labs's estimated annual revenue is currently $390.4M per year.
- Establishment Labs's estimated revenue per employee is $401,600
- Establishment Labs's total funding is $121M.
Employee Data
- Establishment Labs has 972 Employees.
- Establishment Labs grew their employee count by 0% last year.
Establishment Labs's People
| Name | Title | Email/Phone |
|---|---|---|
1 | General Counsel & Chief Human Resources Officer | Reveal Email/Phone |
2 | CEO and Founder | Reveal Email/Phone |
3 | Global VP, Medical Education | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | Head Special Projects | Reveal Email/Phone |
6 | VP & Head U.S Business Unit | Reveal Email/Phone |
7 | SVP Commercial Operations - OUS | Reveal Email/Phone |
8 | VP & Head U.S Business Unit | Reveal Email/Phone |
9 | VP Global Planning | Reveal Email/Phone |
10 | VP / Global Controller | Reveal Email/Phone |
Establishment Labs Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Establishment Labs?
Establishment Labs® (NASDAQ:ESTA) is a global medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market by designing, developing, manufacturing and marketing an innovative portfolio of silicone gel-filled breast implants, branded as Motiva Implants®, the centerpiece of the MotivaImagine® platform. Motiva Implants® are produced at two FDA compliant state-of-the-art facilities in Costa Rica and currently approved for commercial distribution in over 70 countries through exclusive distributors or a direct salesforce. In March 2018, Establishment Labs® received approval for an investigational device exemption (IDE) from the FDA to initiate the Motiva Implants® clinical trial in the United States. In addition to Motiva Implants®, Establishment Labs® product and technologies portfolio includes Divina® 3D Simulation System, Puregraft and MotivaImagine® Centers.
keywords:N/A
$121M
Total Funding
972
Number of Employees
$390.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Establishment Labs News
The stock price of Establishment Labs Holdings Inc (NASDAQ: ESTA) a medical technology company focused on women's health, initially in the...
Establishment Labs (ESTA) received an investigational device exemption from the FDA in 2018 for the Motiva implant. Read why Seeking Alpha's...
Establishment Labs Notes Presentation of 2-Year Results from Motiva US IDE Study at The Aesthetic Meeting 2022. April 21, 2022 06:54 PM Eastern...
Establishment Labs, a NYC-based global medical device company focused on breast surgery technologies, closed an $18m financing round. Backers included Kilowatt Capital and Florence Capital Advisors. The company intends to use the funds to launch Motiva Implants® and Puregraft® in some of the l ...
Establishment Labs, a NYC-based global medical device company, secured up to $15m in debt funding. Backers included Perceptive Advisors, JW Asset Management LLC and Relativity Healthcare Fund. The company intends to use the funds to strengthen its financial position, to continue to expand its ...